Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
Tuesday, February 7, 2012 - 10:31
in Health & Medicine
An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers have shown.